Search
for
Sort by
Research 421–450 of 1000+
- Androgens in cervical cancer: Their role in epidemiology and biology
- International Consensus Guidelines on the Safe and Evidence-Based Practice of Mesotherapy: A Multidisciplinary Statement
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Hepatocyte growth factor combined with adenosine deaminase as biomarker for diagnosis of tuberculous pleural effusion
- Cepharanthine inhibits enterovirus entry by endolysosomal deacidification and exhibits protective activity <i>in vivo</i>
- Advance and Challenges in the Treatment of Skin Diseases with the Transdermal Drug Delivery System
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Traditional Chinese Medicine Shi-Bi-Man regulates lactic acid metabolism and drives hair follicle stem cell activation to promote hair regeneration
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Unusual symptoms of iron deficiency anemia (2 clinical observations)
- COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings
- COVID-19 and Sex Differences
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- COVID‐19 with dermatologic manifestations and implications: An unfolding conundrum
- Telogen effluvium: a sequela of COVID‐19
- COVID‐19 and cutaneous manifestations: A review of the published literature
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Telogen effluvium associated with COVID‐19 infection
- Teledermatology in the COVID-19 pandemic: A systematic review
- Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management
- COVID‐19 and dermatology: a comprehensive guide for dermatologists
- Time of onset and duration of post-COVID-19 acute telogen effluvium
- Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Male balding is a major risk factor for severe COVID-19